SA
CLOV icon

Strategic Advocates’s Clover Health Investments CLOV Stock Holding History

Strategic Advocates’s Portfolio CLOV Stock Details CLOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2
Closed -$5 – 321
2025
Q4 		$5 Sell
2
-4
-67% -$11 ﹤0.01% 635
2025
Q3 		$18 Buy
+6
New +$17 ﹤0.01% 606

Other funds holding CLOV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Strategic Advocates's CLOV Position: Q1 2026 in Review

Strategic Advocates sold out of Clover Health Investments (CLOV) in Q1 2026, closing a stake of 2 shares — an estimated $5 sold.

Strategic Advocates first reported a position in CLOV in Q3 2025 and held it in 2 quarters. The position peaked at $18 in Q3 2025. 208 funds tracked by Wall St. Rank hold CLOV as of Q1 2026.

  • Strategic Advocates reported no remaining Clover Health Investments position as of Q1 2026 after selling out during the quarter.
  • Strategic Advocates sold 2 Clover Health Investments shares in Q1 2026, an estimated $5.
  • Strategic Advocates first reported a position in Clover Health Investments in Q3 2025 and held it in 2 quarters.
  • Strategic Advocates's Clover Health Investments position peaked at $18 in Q3 2025.
  • 208 funds tracked by Wall St. Rank held Clover Health Investments as of Q1 2026.

Based on Strategic Advocates's 13F filing for Q1 2026, filed 15 May 2026.